Korach A, Izhar U, Rudis E, Elami A
Dept. of Cardiothoracic Surgery, Hadassah University Hospital, Jerusalem.
Harefuah. 2000 May 15;138(10):825-8, 911.
Coronary artery disease amenable to percutaneous interventions or coronary artery bypass grafting, and resectable lung cancer are major causes of morbidity and mortality. We present our experience in the treatment of 3 patients (men aged 64 and 66 and a woman of 77) who each had significant coronary artery disease and a resectable lung tumor. They underwent combined coronary artery bypass grafting and pulmonary lobectomy. We conclude from our experience and review of the literature that concomitant surgery in such cases is safe and effective, decreases suffering, and decreases the cost of 2 separate invasive procedures.
适合经皮介入治疗或冠状动脉旁路移植术的冠状动脉疾病以及可切除的肺癌是发病和死亡的主要原因。我们介绍了对3例患者（2名64岁和66岁男性以及1名77岁女性）的治疗经验，他们均患有严重冠状动脉疾病和可切除的肺部肿瘤。他们接受了冠状动脉旁路移植术和肺叶切除术联合手术。我们从自身经验及文献回顾中得出结论，在此类病例中进行联合手术是安全有效的，可减轻痛苦，并降低两次单独侵入性手术的费用。
